LeonaBio, Inc.
LONA
$11.26
$0.262.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 16.68M | 19.11M | 22.63M | 24.88M | 26.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.18M | 39.27M | 57.89M | 78.62M | 96.78M |
| Operating Income | -34.18M | -39.27M | -57.89M | -78.62M | -96.78M |
| Income Before Tax | -105.61M | -37.72M | -59.85M | -79.75M | -96.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -105.61 | -37.72 | -59.85 | -79.75 | -96.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -105.61M | -37.72M | -59.85M | -79.75M | -96.94M |
| EBIT | -34.18M | -39.27M | -57.89M | -78.62M | -96.78M |
| EBITDA | -33.21M | -38.30M | -56.92M | -77.65M | -95.81M |
| EPS Basic | -21.31 | -9.68 | -15.46 | -20.68 | -25.21 |
| Normalized Basic EPS | -5.37 | -6.06 | -9.01 | -12.27 | -15.13 |
| EPS Diluted | -21.31 | -9.68 | -15.46 | -20.68 | -25.21 |
| Normalized Diluted EPS | -5.37 | -6.06 | -9.01 | -12.27 | -15.13 |
| Average Basic Shares Outstanding | 17.10M | 15.63M | 15.54M | 15.46M | 15.39M |
| Average Diluted Shares Outstanding | 17.10M | 15.63M | 15.54M | 15.46M | 15.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |